Poltreg S.a.

This study is testing whether a new cell-based therapy, with or without an antibody drug, can safely delay or prevent the onset of type 1 diabetes in children who are at high risk. About 150 children, aged 6 to 16, who have early signs of the disease but no symptoms, will be rand…